Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Mov Disord. 2007 Apr 15;22(5):720-2.

Malignant melanoma in early Parkinson's disease: the DATATOP trial.

Author information

  • 1Department of Neurology, University of Rochester Medical Center, Rochester, NY 14620, USA. radu.constantinescu@ctcc.rochester.edu

Abstract

The available epidemiological data on the incidence of malignant melanoma in Parkinson's disease are contradictory. The role of levodopa therapy in this context has been debated. We identified all known cases of malignant melanoma (N = 5) in the DATATOP clinical trial cohort and compared that to published expected values (N = 1.5) for a standard healthy population. The standardized event ratio was 3.3 (95% confidence interval, 1.1-7.8), indicating that incidence of malignant melanoma was higher than expected. We found no association between levodopa therapy and the incidence of melanoma.

PMID:
17373726
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk